|
[PMID]: | 28705150 |
[Au] Autor: | Meszner Z; Molnar Z; Rampakakis E; Yang HK; Kuter BJ; Wolfson LJ |
[Ad] Endereço: | St. László Hospital for Infectious Diseases, National Institute of Child Health, Budapest, Hungary. |
[Ti] Título: | Economic burden of varicella in children 1-12 Years of age in Hungary, 2011-2015. |
[So] Source: | BMC Infect Dis;17(1):495, 2017 Jul 14. | [Is] ISSN: | 1471-2334 |
[Cp] País de publicação: | England |
[La] Idioma: | eng |
[Ab] Resumo: | BACKGROUND: Although live-attenuated varicella-zoster virus (VZV) vaccines have been proven to be safe and effective in preventing varicella and real-word evidence shows routine childhood immunization programs are effective in dramatically reducing varicella associated morbidity and mortality, varicella vaccine is not included in the National Immunization Program (NIP) in Hungary. The purpose of this study was to evaluate the clinical and economic burden associated with varicella in Hungary. METHODS: This was a multicenter, retrospective, chart review study of patients aged 1-12 years with a primary varicella diagnosis between 2011 and 2015. Healthcare resource utilization (HCRU) associated with varicella, unit costs, and work loss were used to estimate direct and indirect costs. All costs are presented in 2015 HUF / Euros (€). RESULTS: 156 children with varicella were included (75 outpatients, 81 inpatients), with a mean age of 4.4 (SD: 2.0) and 3.7 (SD: 2.1) years, respectively. One or more complications were reported by 12.0% of outpatients and 92.6% of inpatients, the most common being dehydration, skin and soft tissue infections, pneumonia, keratoconjunctivitis, and cerebellitis. HCRU estimates included use of over-the-counter (OTC) medications (96.0% outpatients, 53.1% inpatients), prescription medications (9.3% outpatients, 70.4% inpatients), tests/procedures (4.0% outpatients, 97.5% inpatients), and consultation with allied health professionals (2.7% outpatients, 30.9% inpatients). The average duration of hospital stay (inpatients) was 3.6 (95% CI: 3.2, 4.1) days. The total combined direct and indirect cost per varicella case was 228,146.7 Hungarian Forint (HUF)/€ 736.0 for inpatients and 49,790.6 HUF/€ 106.6 for outpatients. The overall annual cost of varicella in Hungary for children aged <15 years in 2015 was estimated at 1,903,332,524.3 HUF/ € 6,139,980.4. CONCLUSION: Varicella is associated with substantial clinical burden in Hungary, resulting in the utilization of a significant amount of healthcare resources. These results support the need for routine vaccination of all healthy children to reduce the varicella-associated disease burden. |
[Mh] Termos MeSH primário: |
Varicela/economia Varicela/epidemiologia
|
[Mh] Termos MeSH secundário: |
Varicela/prevenção & controle Varicela/terapia Vacina contra Varicela/economia Vacina contra Varicela/uso terapêutico Criança Pré-Escolar Custos e Análise de Custo Feminino Seres Humanos Hungria/epidemiologia Programas de Imunização/economia Lactente Pacientes Internados Tempo de Internação Masculino Morbidade Pacientes Ambulatoriais Estudos Retrospectivos
|
[Pt] Tipo de publicação: | JOURNAL ARTICLE; MULTICENTER STUDY; OBSERVATIONAL STUDY |
[Nm] Nome de substância:
| 0 (Chickenpox Vaccine) |
[Em] Mês de entrada: | 1710 |
[Cu] Atualização por classe: | 171010 |
[Lr] Data última revisão:
| 171010 |
[Sb] Subgrupo de revista: | IM |
[Da] Data de entrada para processamento: | 170715 |
[St] Status: | MEDLINE |
[do] DOI: | 10.1186/s12879-017-2575-6 |
|
|
|